A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivity

TAK-243 is a first-in-class inhibitor of ubiquitin-like modifier activating enzyme 1 that catalyzes ubiquitin activation, the first step in the ubiquitylation cascade. Based on its preclinical efficacy and tolerability, TAK-243 has been advanced to phase I clinical trials in advanced malignancies. N...

Descripción completa

Detalles Bibliográficos
Autores principales: Barghout, Samir H., Aman, Ahmed, Nouri, Kazem, Blatman, Zachary, Arevalo, Karen, Thomas, Geethu E., MacLean, Neil, Hurren, Rose, Ketela, Troy, Saini, Mehakpreet, Abohawya, Moustafa, Kiyota, Taira, Al-Awar, Rima, Schimmer, Aaron D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021101/
https://www.ncbi.nlm.nih.gov/pubmed/33476303
http://dx.doi.org/10.1172/jci.insight.141518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021101/
https://www.ncbi.nlm.nih.gov/pubmed/33476303
http://dx.doi.org/10.1172/jci.insight.141518

Ejemplares similares